These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 27386725)
41. Procalcitonin-guided therapy for the initiation of antibiotics in the ED: a systematic review. van der Does Y; Rood PP; Haagsma JA; Patka P; van Gorp EC; Limper M Am J Emerg Med; 2016 Jul; 34(7):1286-93. PubMed ID: 27130585 [TBL] [Abstract][Full Text] [Related]
42. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B; JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090 [TBL] [Abstract][Full Text] [Related]
43. [A Cochrane meta-analysis regarding procalcitonin is in accordance with international goals for the use of antibiotics]. Berg PL; Lindhardt BO Ugeskr Laeger; 2013 Dec; 175(50):3093-6. PubMed ID: 24629531 [TBL] [Abstract][Full Text] [Related]
44. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Schuetz P; Bolliger R; Merker M; Christ-Crain M; Stolz D; Tamm M; Luyt CE; Wolff M; Schroeder S; Nobre V; Reinhart K; Branche A; Damas P; Nijsten M; Deliberato RO; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Beishuizen A; de Jong E; Briel M; Welte T; Mueller B Expert Rev Anti Infect Ther; 2018 Jul; 16(7):555-564. PubMed ID: 29969320 [TBL] [Abstract][Full Text] [Related]
45. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations. Tokman S; Schuetz P; Bent S Expert Rev Anti Infect Ther; 2011 Jun; 9(6):727-35. PubMed ID: 21692680 [TBL] [Abstract][Full Text] [Related]
46. Do we need new trials of procalcitonin-guided antibiotic therapy? Lisboa T; Salluh J; Povoa P Crit Care; 2018 Jan; 22(1):17. PubMed ID: 29373980 [TBL] [Abstract][Full Text] [Related]
47. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial. Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632 [TBL] [Abstract][Full Text] [Related]
48. Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions. Wirz Y; Branche A; Wolff M; Welte T; Nobre V; Reinhart K; Falsey AR; Damas P; Beishuizen A; Deliberato RO; Shehabi Y; Jensen JS; Mueller B; Schuetz P ACS Infect Dis; 2017 Dec; 3(12):875-879. PubMed ID: 29120606 [TBL] [Abstract][Full Text] [Related]
49. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Schuetz P; Raad I; Amin DN Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026 [TBL] [Abstract][Full Text] [Related]
51. Serum procalcitonin levels: comment on "Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in 'real life'". Gilbert D Arch Intern Med; 2012 May; 172(9):722-3. PubMed ID: 22782202 [No Abstract] [Full Text] [Related]
52. [Procalcitonin: should it be measured systemically?]. Luong Ba K; Harbarth S; Carballo S Rev Med Suisse; 2013 Oct; 9(402):1881-2, 1884-5. PubMed ID: 24298711 [TBL] [Abstract][Full Text] [Related]
53. Procalcitonin-guided antibiotic stewardship from newborns to centennials. Schuetz P; Mueller B Lancet; 2017 Aug; 390(10097):826-829. PubMed ID: 28711319 [No Abstract] [Full Text] [Related]
54. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial. Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B; PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346 [TBL] [Abstract][Full Text] [Related]
56. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis? Harrison M; Collins CD Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167 [TBL] [Abstract][Full Text] [Related]
57. Role of procalcitonin in managing adult patients with respiratory tract infections. Schuetz P; Amin DN; Greenwald JL Chest; 2012 Apr; 141(4):1063-1073. PubMed ID: 22474148 [TBL] [Abstract][Full Text] [Related]
58. [Interpretation of the concentrations of procalcitonin during infectious and inflammatory processes]. Piatnitskiĭ IA; Sharandak AP; Zokina TG; Berner LP Ter Arkh; 2012; 84(12):120-4. PubMed ID: 23480003 [TBL] [Abstract][Full Text] [Related]
59. [Is procalcitonin measurement useful in managing respiratory tract infections?]. Prins JM; van der Poll T Ned Tijdschr Geneeskd; 2016; 160():D957. PubMed ID: 27734780 [TBL] [Abstract][Full Text] [Related]